Nu Skin Enterprises, Inc. (NUS) DCF Valuation

Nu Skin Enterprises, Inc. (NUS) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Nu Skin Enterprises, Inc. (NUS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to calculate the intrinsic value of Nu Skin Enterprises, Inc.? Our (NUS) DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your projections and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 2,420.4 2,581.9 2,695.7 2,225.7 1,969.1 1,881.1 1,797.0 1,716.7 1,639.9 1,566.6
Revenue Growth, % 0 6.67 4.41 -17.44 -11.53 -4.47 -4.47 -4.47 -4.47 -4.47
EBITDA 267.4 331.6 368.5 231.8 137.7 206.8 197.6 188.7 180.3 172.2
EBITDA, % 11.05 12.84 13.67 10.42 6.99 10.99 10.99 10.99 10.99 10.99
Depreciation 121.1 120.2 125.0 72.5 69.6 79.3 75.8 72.4 69.2 66.1
Depreciation, % 5 4.65 4.64 3.26 3.53 4.22 4.22 4.22 4.22 4.22
EBIT 146.3 211.4 243.5 159.3 68.1 127.5 121.8 116.3 111.1 106.2
EBIT, % 6.05 8.19 9.03 7.16 3.46 6.78 6.78 6.78 6.78 6.78
Total Cash 344.0 423.9 354.8 278.5 267.8 263.0 251.3 240.0 229.3 219.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 50.4 63.4 41.3 47.4 72.9
Account Receivables, % 2.08 2.45 1.53 2.13 3.7
Inventories 275.9 314.4 399.9 346.2 280.0 256.5 245.0 234.1 223.6 213.6
Inventories, % 11.4 12.18 14.84 15.55 14.22 13.64 13.64 13.64 13.64 13.64
Accounts Payable 39.0 66.2 50.0 54.0 43.5 40.1 38.3 36.6 35.0 33.4
Accounts Payable, % 1.61 2.56 1.85 2.42 2.21 2.13 2.13 2.13 2.13 2.13
Capital Expenditure -66.1 -63.8 -68.6 -59.1 -58.5 -50.3 -48.1 -45.9 -43.9 -41.9
Capital Expenditure, % -2.73 -2.47 -2.55 -2.65 -2.97 -2.67 -2.67 -2.67 -2.67 -2.67
Tax Rate, % 67.66 67.66 67.66 67.66 67.66 67.66 67.66 67.66 67.66 67.66
EBITAT 99.5 157.9 154.2 187.7 22.0 86.3 82.4 78.7 75.2 71.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -132.7 189.9 131.0 252.8 63.3 163.5 121.8 116.4 111.2 106.2
WACC, % 5.44 5.63 5.3 6.35 4.42 5.43 5.43 5.43 5.43 5.43
PV UFCF
SUM PV UFCF 535.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 108
Terminal Value 3,159
Present Terminal Value 2,426
Enterprise Value 2,961
Net Debt 351
Equity Value 2,610
Diluted Shares Outstanding, MM 50
Equity Value Per Share 52.34

What You Will Get

  • Real NUS Financial Data: Pre-filled with Nu Skin’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Nu Skin’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Nu Skin Enterprises, Inc. (NUS).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic recalculations for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to clearly present your valuation insights.
  • Suitable for All Skill Levels: Designed with a straightforward layout for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the comprehensive Excel file containing Nu Skin Enterprises, Inc.'s (NUS) financial data.
  • Customize: Modify projections, including sales growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and instantly compare results.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose Nu Skin Enterprises, Inc. (NUS)?

  • Innovative Products: Experience cutting-edge skincare and wellness solutions that stand out in the market.
  • Proven Track Record: Benefit from a company with decades of success and a strong reputation in the industry.
  • Global Reach: Access a vast network of distributors and customers worldwide, enhancing market opportunities.
  • Commitment to Quality: Rely on high-quality standards and rigorous testing for all products.
  • Empowering Community: Join a supportive environment that encourages personal growth and business success.

Who Should Use This Product?

  • Beauty and Wellness Students: Explore marketing strategies and product development using real-world examples from Nu Skin Enterprises, Inc. (NUS).
  • Researchers: Utilize industry-leading models in your studies on skincare and wellness trends.
  • Investors: Evaluate your investment strategies and analyze financial performance for Nu Skin Enterprises, Inc. (NUS).
  • Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model tailored for the beauty industry.
  • Entrepreneurs: Discover insights into how successful companies like Nu Skin Enterprises, Inc. (NUS) operate and grow.

What the Template Contains

  • Pre-Filled Data: Includes Nu Skin Enterprises, Inc.'s (NUS) historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Nu Skin Enterprises, Inc.'s (NUS) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.